首页 | 本学科首页   官方微博 | 高级检索  
检索        


Antiatherogenic actions of etidronate on atherosclerosis
Authors:Koshiyama Hiroyuki
Institution:Division of Endocrinology and Metabolism, Department of Internal Medicine, Hyogo Prefectural Amagasaki Hospital.
Abstract:Bisphosphonates including etidronate have been suggested to have antiatherogenic actions in experimental animals or in vitro. However, there has been no report indicating that bisphosphonates have antiatherogenic actions in humans. We have recently reported that etidronate, one of the bisphosphonates, decreased the intima-media thickness in subjects with type 2 diabetes, indicating a possibility that etidronate may have antiatherogenic action in humans.
Keywords:
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号